off-label use

A judge has finalized Allergan's $600 million settlement over the misleading marketing of its wrinkle-smoothing Botox medication. The pharmaceutical firm plead guilty to misbranding the product.

Botox may ease wrinkles, but a $600 million government fine today of its manufacturer Allergan is making clear it's not a legal remedy for headaches, pains and juvenile cerebral palsy. The Justice Department today came down hard on Allergan for making such claims, announcing a settlement that has...